Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-25-011625

Director sold 2,000 shares at $219.74 ($439,480)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

FARRELL PETER C · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-04-02 Sale : show line 1 in the form 10b5-1 −2,000 $219.74 $439,480 73,218 D
Open-market sales · 2,000 sh · avg $219.74 · $439,480
Loading xslF345X05/form4.xml…